Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis

BACKGROUND: Vaccination against the oncogenic human papillomavirus (HPV) types 16 and 18 will reduce the prevalence of these types, thereby also reducing cervical cancer risk in unvaccinated women. This (measurable) herd effect will be limited at first, but is expected to increase over time. At a ce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Naber, Steffie K., Matthijsse, Suzette M., Rozemeijer, Kirsten, Penning, Corine, de Kok, Inge M. C. M., van Ballegooijen, Marjolein
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4732771/
https://ncbi.nlm.nih.gov/pubmed/26824771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0145548
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados